Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent. The everolimus-eluting resorbable scaffold system treats chronic limb-threatening ischemia (CLTI) below the knee (BTK). Abbott … [Read More...] about Abbott reports sustained benefits with Esprit drug-eluting stent
Main Content
Sponsored Content
Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Manufacturing automation is crucial to achieving the precision, quality, and volume required in the medical device industry. Advanced robotics, AI, modular designs, and wireless technology offer the … [Read More...] about Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI
Featured Posts
Medtronic wins FDA nod for new InPen app to support launch with Simplera CGM
Medtronic (NYSE:MDT) announced today that it received FDA clearance for its new InPen insulin delivery system application. The app features missed meal dose detection and paves the way for the launch of the company's smart multiple daily injection … [Read More...] about Medtronic wins FDA nod for new InPen app to support launch with Simplera CGM
Insulet Omnipod 5 is now compatible with Abbott FreeStyle Libre 2 Plus in the U.S.
Insulet (Nasdaq:PODD) today announced compatibility between its Omnipod 5 insulin pump and the Abbott (NYSE:ABT) FreeStyle Libre 2 Plus CGM in the U.S. The company says this latest integration makes Omnipod 5 the most connected tubeless automated … [Read More...] about Insulet Omnipod 5 is now compatible with Abbott FreeStyle Libre 2 Plus in the U.S.
Dexcom invests $75M in Oura as companies strike health monitoring partnership
Dexcom (Nasdaq:DXCM) announced today that it entered into a strategic partnership with Oura, maker of leading smart ring technology. The partnership aims to help people improve their metabolic health by integrating Dexcom glucose data with vital … [Read More...] about Dexcom invests $75M in Oura as companies strike health monitoring partnership
Medtronic to submit MiniMed 780G to FDA for type 2 diabetes in 2025, updates on patch pump
Medtronic (NYSE:MDT) has plans to submit its MiniMed 780G for an expanded indication from the FDA for type 2 diabetes in the near future. On the company's second-quarter earnings call, Que Dallara, EVP and president of Medtronic Diabetes outlined … [Read More...] about Medtronic to submit MiniMed 780G to FDA for type 2 diabetes in 2025, updates on patch pump
Abbott opens new FreeStyle Libre manufacturing plant in Ireland
Abbott (NYSE:ABT) announced today that it officially opened a new state-of-the-art manufacturing facility in Kilkenny, Ireland. The site serves as a global manufacturing center of excellence for Abbott's Diabetes Care business. The company expects … [Read More...] about Abbott opens new FreeStyle Libre manufacturing plant in Ireland
The biggest diabetes tech stories of the year so far
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space. The date, which marks the birth date of the inventor of insulin, brings out all sorts of initiatives from various companies involved in … [Read More...] about The biggest diabetes tech stories of the year so far
What diabetes tech companies are doing on World Diabetes Day 2024
World Diabetes Day — today, Nov. 14 — brings out the best in the diabetes community that continues to innovate year after year. This date serves as a time to recognize these innovations as it marks the birthday of Sir Frederick Banting. Banting … [Read More...] about What diabetes tech companies are doing on World Diabetes Day 2024
Dexcom highlights diabetes awareness with global star power
Dexcom (Nasdaq:DXCM) today announced survey data outlining the importance of raising awareness of diabetes. The company surveyed 2,250 individuals all over the world over 18 with type 1 or type 2 diabetes. Nearly 70% of people with diabetes say … [Read More...] about Dexcom highlights diabetes awareness with global star power
Beta Bionics raises $60M Series E to support iLet bionic pancreas
Beta Bionics announced today that it closed a Series E preferred stock financing round worth a total of $60 million. This funding round adds to the $100 million Series D financing Beta Bionics completed in August 2023. Irvine, California-based … [Read More...] about Beta Bionics raises $60M Series E to support iLet bionic pancreas
Avanos Medical earns Medicare win for infusion pump tech
Avanos Medical announced today that a Centers for Medicare and Medicaid Services (CMS) payment rule benefits its infusion systems. CMS issued its final Medicare Hospital Outpatient Prospective Payment System (OPPS) and Medicare Ambulatory Surgical … [Read More...] about Avanos Medical earns Medicare win for infusion pump tech
In case you missed it
- Senseonics reports mixed Q3 results, positive Eversense 365 outlook
- Insulet stock rises on Q3 beat, raised sales guidance
- Tandem stock rises on 31% Q3 sales growth, raised guidance
- Insulin pump maker PharmaSens adds former ADA leaders, medtech veterans to board
- Abbott reports sustained benefits with Esprit drug-eluting stent
- R3 Vascular wins FDA IDE for drug-eluting scaffold
- Medtronic kicks off Blue Balloon Challenge for National Diabetes Awareness Month
- Insulet announces diabetes awareness initiatives for November
- FDA approves Abbott CGMs for use during medical imaging
- Beta Bionics launches iLet bionic pancreas with Abbott FreeStyle Libre 3 Plus
- Insulet fully launches Omnipod 5 app for iPhone in U.S.
- Insulcloud wins FDA nod to bring smart insulin pen cap tech to U.S.
- Tidepool, Abbott collab on data integration for FreeStyle Libre
- Senseonics announces $16M registered direct offering
- Dexcom submits 15-day CGM to FDA, beats Street in Q3
Clinical Trials
Abbott reports sustained benefits with Esprit drug-eluting stent
Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent. The everolimus-eluting resorbable scaffold system treats chronic limb-threatening ischemia (CLTI) below the knee (BTK). Abbott designed it to keep arteries open and deliver everolimus to support vessel healing prior to completely dissolving. The first-of-its-kind stent provides support to the vessel […]
Elixir Medical has positive data for drug-eluting bioadaptive implant
Elixir Medical announced positive data demonstrating the benefit of its DynamX coronary bioadaptor system in target lesion failure (TLF). Data highlighted the success of DynamX compared to Medtronic’s Resolute Onyx zotarolimus drug-eluting stent (DES). The study looked at complex patient populations within the INFINITY-SWEDEHEART randomized controlled trial. Data included an analysis of patients with acute […]
Luna Diabetes launches trial for ‘world’s smallest insulin patch pump’
Luna Diabetes announced that it launched its pivotal trial for Luna, the company’s miniature automated insulin delivery system. The company describes the system — designed to transform nighttime glucose management — as the world’s smallest patch pump. Luna delivers micro-doses of insulin while the user sleeps. According to the company, it offers the “simplest onboarding […]
SpyGlass Pharma shares positive data for drug-eluting intraocular lens
SpyGlass Pharma released 18-month follow-up data highlighting the potential of its intraocular lens (IOL)-based drug delivery platform. Data came from a first-in-human study of 23 patients with glaucoma or ocular hypertension. They received the IOL implant at the time of cataract surgery. The company reported a consistent sustained reduction of intraocular pressure (IOP) across all […]
NIH launches effort to combat type 2 diabetes in young people
The National Institutes of Health (NIH) launched a nationwide consortium to address the rise in youth diagnosed with type 2 diabetes. According to a press release, NIH expects that trend — which it observed over the past two decades — to continue moving forward. It aims to advance understanding of the biologic, social, and environmental […]
